Search

Amber D. Steele

Examiner (ID: 11314, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1639, 1654, 1676, 1658
Total Applications
1278
Issued Applications
622
Pending Applications
159
Abandoned Applications
534

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5331379 [patent_doc_number] => 20090111856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'Parenteral Formulation Comprising Proton Pump Inhibitor Sterilized in its Final Container by Ionizing Radiation' [patent_app_type] => utility [patent_app_number] => 12/299684 [patent_app_country] => US [patent_app_date] => 2007-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5507 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111856.pdf [firstpage_image] =>[orig_patent_app_number] => 12299684 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/299684
Parenteral Formulation Comprising Proton Pump Inhibitor Sterilized in its Final Container by Ionizing Radiation May 6, 2007 Abandoned
Array ( [id] => 4860487 [patent_doc_number] => 20080269337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Method for the enhancing biocidal activity' [patent_app_type] => utility [patent_app_number] => 11/796863 [patent_app_country] => US [patent_app_date] => 2007-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3493 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269337.pdf [firstpage_image] =>[orig_patent_app_number] => 11796863 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/796863
Method for the enhancing biocidal activity Apr 29, 2007 Abandoned
Array ( [id] => 9413679 [patent_doc_number] => 08697716 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Method of inhibiting C-KIT kinase' [patent_app_type] => utility [patent_app_number] => 11/737517 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49869 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11737517 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/737517
Method of inhibiting C-KIT kinase Apr 18, 2007 Issued
Array ( [id] => 5436258 [patent_doc_number] => 20090170845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'USE OF IMIDAZO[2,1-b]-1,3,4-THIADIAZOLE-2-SULFONAMIDE COMPOUNDS TO TREAT NEUROPATHIC PAIN' [patent_app_type] => utility [patent_app_number] => 12/296810 [patent_app_country] => US [patent_app_date] => 2007-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12566 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170845.pdf [firstpage_image] =>[orig_patent_app_number] => 12296810 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/296810
USE OF IMIDAZO[2,1-b]-1,3,4-THIADIAZOLE-2-SULFONAMIDE COMPOUNDS TO TREAT NEUROPATHIC PAIN Apr 12, 2007 Abandoned
Array ( [id] => 9232864 [patent_doc_number] => 08598168 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-03 [patent_title] => 'Inhibitors of histone deacetylase' [patent_app_type] => utility [patent_app_number] => 11/696880 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 92598 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11696880 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/696880
Inhibitors of histone deacetylase Apr 4, 2007 Issued
Array ( [id] => 5284462 [patent_doc_number] => 20090098137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 12/294141 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15758 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098137.pdf [firstpage_image] =>[orig_patent_app_number] => 12294141 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/294141
COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER Apr 4, 2007 Abandoned
Array ( [id] => 5374750 [patent_doc_number] => 20090312311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'COMBINATION OF ORGANIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/225958 [patent_app_country] => US [patent_app_date] => 2007-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13639 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312311.pdf [firstpage_image] =>[orig_patent_app_number] => 12225958 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/225958
COMBINATION OF ORGANIC COMPOUNDS Apr 3, 2007 Abandoned
Array ( [id] => 6038403 [patent_doc_number] => 20110091452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => '4,5-Dihydromacbecin Derivatives and Their Use in the Treatment of Cancer or B-Cell Malignancies' [patent_app_type] => utility [patent_app_number] => 12/294175 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16652 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091452.pdf [firstpage_image] =>[orig_patent_app_number] => 12294175 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/294175
4,5-Dihydromacbecin Derivatives and Their Use in the Treatment of Cancer or B-Cell Malignancies Mar 29, 2007 Abandoned
Array ( [id] => 6508412 [patent_doc_number] => 20100210635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'RENIN INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/294906 [patent_app_country] => US [patent_app_date] => 2007-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 45149 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210635.pdf [firstpage_image] =>[orig_patent_app_number] => 12294906 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/294906
RENIN INHIBITORS Mar 22, 2007 Abandoned
Array ( [id] => 6007946 [patent_doc_number] => 20110059977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'USE OF CANTHIN-6-ONE AND ITS ANALOGS IN THE TREATMENT OF MYCOBACTERIA-LINKED PATHOLOGIES ( amended' [patent_app_type] => utility [patent_app_number] => 12/294668 [patent_app_country] => US [patent_app_date] => 2007-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6603 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059977.pdf [firstpage_image] =>[orig_patent_app_number] => 12294668 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/294668
USE OF CANTHIN-6-ONE AND ITS ANALOGS IN THE TREATMENT OF MYCOBACTERIA-LINKED PATHOLOGIES ( amended Mar 21, 2007 Abandoned
Array ( [id] => 4976781 [patent_doc_number] => 20070218012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Pharmaceutical Compositions' [patent_app_type] => utility [patent_app_number] => 11/687779 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18062 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20070218012.pdf [firstpage_image] =>[orig_patent_app_number] => 11687779 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/687779
Pharmaceutical Compositions Mar 18, 2007 Abandoned
Array ( [id] => 4693151 [patent_doc_number] => 20080085922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'METHODS AND OPHTHALMIC DEVICES USED IN THE TREATMENT OF OCULAR ALLERGIES' [patent_app_type] => utility [patent_app_number] => 11/686979 [patent_app_country] => US [patent_app_date] => 2007-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5448 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085922.pdf [firstpage_image] =>[orig_patent_app_number] => 11686979 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/686979
Methods and ophthalmic devices used in the treatment of ocular allergies Mar 15, 2007 Issued
Array ( [id] => 5576054 [patent_doc_number] => 20090143416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Method of Inducing Tolerance of Plants Against Bacterioses' [patent_app_type] => utility [patent_app_number] => 12/223029 [patent_app_country] => US [patent_app_date] => 2007-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7388 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143416.pdf [firstpage_image] =>[orig_patent_app_number] => 12223029 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/223029
Method of Inducing Tolerance of Plants Against Bacterioses Mar 5, 2007 Abandoned
Array ( [id] => 5447026 [patent_doc_number] => 20090048252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/281181 [patent_app_country] => US [patent_app_date] => 2007-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40540 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048252.pdf [firstpage_image] =>[orig_patent_app_number] => 12281181 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/281181
THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS Mar 1, 2007 Abandoned
Array ( [id] => 5527838 [patent_doc_number] => 20090197915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'SIGMA RECEPTOR COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/281300 [patent_app_country] => US [patent_app_date] => 2007-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19739 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197915.pdf [firstpage_image] =>[orig_patent_app_number] => 12281300 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/281300
Sigma receptor compounds Mar 1, 2007 Issued
Array ( [id] => 5291012 [patent_doc_number] => 20090023742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/281179 [patent_app_country] => US [patent_app_date] => 2007-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25489 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023742.pdf [firstpage_image] =>[orig_patent_app_number] => 12281179 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/281179
THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS Mar 1, 2007 Abandoned
Array ( [id] => 5285584 [patent_doc_number] => 20090099259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Method for regulating gene expression' [patent_app_type] => utility [patent_app_number] => 11/712102 [patent_app_country] => US [patent_app_date] => 2007-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23528 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099259.pdf [firstpage_image] =>[orig_patent_app_number] => 11712102 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/712102
Method for regulating gene expression Feb 27, 2007 Abandoned
Array ( [id] => 5297206 [patent_doc_number] => 20090012132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Pharmaceutical Package' [patent_app_type] => utility [patent_app_number] => 12/224363 [patent_app_country] => US [patent_app_date] => 2007-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5579 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012132.pdf [firstpage_image] =>[orig_patent_app_number] => 12224363 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/224363
Pharmaceutical Package Feb 25, 2007 Abandoned
Array ( [id] => 7518926 [patent_doc_number] => 07973027 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Compound with antimalarial activity and antimalarial drug containing the same as active ingredient' [patent_app_type] => utility [patent_app_number] => 12/224387 [patent_app_country] => US [patent_app_date] => 2007-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4533 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/973/07973027.pdf [firstpage_image] =>[orig_patent_app_number] => 12224387 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/224387
Compound with antimalarial activity and antimalarial drug containing the same as active ingredient Feb 25, 2007 Issued
Array ( [id] => 5005648 [patent_doc_number] => 20070203220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Inhibitors Of PAI-1 For Treatment Of Muscular Conditions' [patent_app_type] => utility [patent_app_number] => 11/679031 [patent_app_country] => US [patent_app_date] => 2007-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21913 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203220.pdf [firstpage_image] =>[orig_patent_app_number] => 11679031 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/679031
Inhibitors Of PAI-1 For Treatment Of Muscular Conditions Feb 25, 2007 Abandoned
Menu